DC
HOLX

Davenport & Co’s Hologic HOLX Stock Holding History

Davenport & Co’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-38,169
Closed -$2.46M – 1014
2022
Q3 		$2.46M Sell
38,169
-795
-2% -$55.1K 0.02% 327
2022
Q2 		$2.7M Sell
38,964
-25,578
-40% -$1.9M 0.02% 322
2022
Q1 		$4.96M Sell
64,542
-3,603
-5% -$259K 0.03% 266
2021
Q4 		$5.22M Buy
68,145
+32,730
+92% +$2.41M 0.03% 261
2021
Q3 		$2.61M Buy
35,415
+29,260
+475% +$2.19M 0.02% 338
2021
Q2 		$411K Buy
+6,155
New +$411K ﹤0.01% 702
2015
Q2 		– Sell
-9,500
Closed -$314K – 610
2015
Q1 		$314K Hold
9,500
– – ﹤0.01% 468
2014
Q4 		$254K Hold
9,500
– – ﹤0.01% 499
2014
Q3 		$231K Hold
9,500
– – ﹤0.01% 516
2014
Q2 		$241K Hold
9,500
– – ﹤0.01% 516
2014
Q1 		$204K Buy
+9,500
New +$205K ﹤0.01% 534

Other funds holding HOLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Davenport & Co's HOLX Position: Q4 2022 in Review

Davenport & Co sold out of Hologic (HOLX) in Q4 2022, closing a stake of 38,169 shares — an estimated $2.46M sold.

Davenport & Co first reported a position in HOLX in Q1 2014 and held it in 11 quarters. The position peaked at $5.22M in Q4 2021. 697 funds tracked by Wall St. Rank hold HOLX as of Q4 2022.

  • Davenport & Co reported no remaining Hologic position as of Q4 2022 after selling out during the quarter.
  • Davenport & Co sold 38,169 Hologic shares in Q4 2022, an estimated $2.46M.
  • Davenport & Co first reported a position in Hologic in Q1 2014 and held it in 11 quarters.
  • Davenport & Co's Hologic position peaked at $5.22M in Q4 2021.
  • 697 funds tracked by Wall St. Rank held Hologic as of Q4 2022.

Based on Davenport & Co's 13F filing for Q4 2022, filed 20 Jan 2023.